These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30914422)

  • 1. Correlation of changes in serum level of VEGF and peripapillary retinal thickness in patients with POEMS syndrome.
    Yokouchi H; Baba T; Misawa S; Oshitari T; Kuwabara S; Yamamoto S
    Br J Ophthalmol; 2020 Jan; 104(1):33-38. PubMed ID: 30914422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome.
    Yokouchi H; Baba T; Misawa S; Sawai S; Kitahashi M; Oshitari T; Kuwabara S; Yamamoto S
    Br J Ophthalmol; 2016 Jul; 100(7):897-901. PubMed ID: 26504179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OCULAR MANIFESTATIONS AND TREATMENT OUTCOMES IN CHINESE PATIENTS WITH POEMS SYNDROME.
    Zhang X; Cai QQ; Huang XF; Cao XX; Cai H; Zhou DB; Dai RP; Li J
    Retina; 2017 Sep; 37(9):1784-1791. PubMed ID: 27930460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome.
    Yokouchi H; Baba T; Misawa S; Kitahashi M; Oshitari T; Kuwabara S; Yamamoto S
    Br J Ophthalmol; 2017 Jun; 101(6):786-790. PubMed ID: 27707692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between serum level of vascular endothelial growth factor and subfoveal choroidal thickness in patients with POEMS syndrome.
    Yokouchi H; Baba T; Misawa S; Sawai S; Beppu M; Kitahashi M; Oshitari T; Kuwabara S; Yamamoto S
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1641-6. PubMed ID: 25367833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic disc edema, cystoid macular edema, and elevated vascular endothelial growth factor in a patient with POEMS syndrome.
    Chong DY; Comer GM; Trobe JD
    J Neuroophthalmol; 2007 Sep; 27(3):180-3. PubMed ID: 17895817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of optic disc edema area in estimating the severity of papilledema in patients with POEMS syndrome.
    Liu LS; Zhang X; Zhao H; Gao XM; Zhou DB; Dai RP; Li J
    Orphanet J Rare Dis; 2020 May; 15(1):116. PubMed ID: 32429967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide reduces choroidal thickness and optic disc edema in a patient with POEMS syndrome.
    Yokouchi H; Oshitari T; Baba T; Yamamoto S
    Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):1195-8. PubMed ID: 25550097
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
    Misawa S; Sato Y; Katayama K; Hanaoka H; Sawai S; Beppu M; Nomura F; Shibuya K; Sekiguchi Y; Iwai Y; Watanabe K; Amino H; Ohwada C; Takeuchi M; Sakaida E; Nakaseko C; Kuwabara S
    BMJ Open; 2015 Nov; 5(11):e009157. PubMed ID: 26560063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of POEMS syndrome with cystoid macular edema.
    Imai H; Kusuhara S; Nakanishi Y; Teraoka Escaño MF; Yamamoto H; Tsukahara Y; Negi A
    Am J Ophthalmol; 2005 Mar; 139(3):563-6. PubMed ID: 15767082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome.
    Kuwabara S; Misawa S; Kanai K; Sawai S; Hattori T; Nishimura M; Nakaseko C
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1255-7. PubMed ID: 18469028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
    He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
    Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
    Misawa S; Sato Y; Katayama K; Nagashima K; Aoyagi R; Sekiguchi Y; Sobue G; Koike H; Yabe I; Sasaki H; Watanabe O; Takashima H; Nishizawa M; Kawachi I; Kusunoki S; Mitsui Y; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
    Lancet Neurol; 2016 Oct; 15(11):1129-37. PubMed ID: 27496680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in choroidal vascular structures due to serum levels of vascular endothelial growth factor in patients with POEMS syndrome.
    Yokouchi H; Nagasato D; Mitamura Y; Egawa M; Tabuchi H; Misawa S; Kuwabara S; Baba T
    Sci Rep; 2023 Jun; 13(1):10650. PubMed ID: 37391497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients.
    Lestang E; Caristan A; Néel A; Graveleau J; Duhamel E; Masseau A; Connault J; Maisonneuve H; Le Gouill S; Blin N; Touzeau C; Moreau P; Hamidou M
    Leuk Lymphoma; 2015 Jun; 56(6):1895-6. PubMed ID: 25347429
    [No Abstract]   [Full Text] [Related]  

  • 16. Optical coherence tomography features of POEMS syndrome and Castleman disease-associated papillopathy.
    Ecsedy M; Schneider M; Nemes J; Nemeth J; Recsan Z
    Ocul Immunol Inflamm; 2014 Dec; 22(6):454-60. PubMed ID: 24564641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis.
    Scarlato M; Previtali SC; Carpo M; Pareyson D; Briani C; Del Bo R; Nobile-Orazio E; Quattrini A; Comi GP
    Brain; 2005 Aug; 128(Pt 8):1911-20. PubMed ID: 15975949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial.
    Suichi T; Misawa S; Nagashima K; Sato Y; Iwai Y; Katayama K; Sekiguchi Y; Shibuya K; Amino H; Suzuki YI; Tsuneyama A; Nakamura K; Kuwabara S
    Intern Med; 2020 May; 59(9):1149-1153. PubMed ID: 32009091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple angiogenetic factors are upregulated in POEMS syndrome.
    Yamada Y; Sawai S; Misawa S; Kanai K; Shibuya K; Mori M; Moriya J; Sogawa K; Yamamoto H; Beppu M; Taniguchi J; Nakaseko C; Nomura F; Kuwabara S
    Ann Hematol; 2013 Jan; 92(2):245-8. PubMed ID: 23053181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
    Barete S; Mouawad R; Choquet S; Viala K; Leblond V; Musset L; Amoura Z; Khayat D; Francès C
    Arch Dermatol; 2010 Jun; 146(6):615-23. PubMed ID: 20566924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.